305 related articles for article (PubMed ID: 25626326)
1. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Rolston DD; Hernandez AV; Donskey CJ; Fraser TG
Infect Control Hosp Epidemiol; 2015 Apr; 36(4):452-60. PubMed ID: 25626326
[TBL] [Abstract][Full Text] [Related]
2. Recurrent
Song JH; Kim YS
Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
4. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
[TBL] [Abstract][Full Text] [Related]
6. The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Phatharacharukul P; Thongprayoon C; Cheungpasitporn W; Edmonds PJ; Mahaparn P; Bruminhent J
Dig Dis Sci; 2015 Oct; 60(10):2913-22. PubMed ID: 25986528
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for
Eze P; Balsells E; Kyaw MH; Nair H
J Glob Health; 2017 Jun; 7(1):010417. PubMed ID: 28607673
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
Gupta SB; Mehta V; Dubberke ER; Zhao X; Dorr MB; Guris D; Molrine D; Leney M; Miller M; Dupin M; Mast TC
Clin Infect Dis; 2016 Sep; 63(6):730-734. PubMed ID: 27365387
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
[TBL] [Abstract][Full Text] [Related]
11. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review.
Anjewierden S; Han Z; Foster CB; Pant C; Deshpande A
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):420-426. PubMed ID: 30841948
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.
Garey KW; Sethi S; Yadav Y; DuPont HL
J Hosp Infect; 2008 Dec; 70(4):298-304. PubMed ID: 18951661
[TBL] [Abstract][Full Text] [Related]
17. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.
Zacharioudakis IM; Zervou FN; Pliakos EE; Ziakas PD; Mylonakis E
Am J Gastroenterol; 2015 Mar; 110(3):381-90; quiz 391. PubMed ID: 25732416
[TBL] [Abstract][Full Text] [Related]
18. Microbiologic factors affecting Clostridium difficile recurrence.
Chilton CH; Pickering DS; Freeman J
Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
Sheitoyan-Pesant C; Abou Chakra CN; Pépin J; Marcil-Héguy A; Nault V; Valiquette L
Clin Infect Dis; 2016 Mar; 62(5):574-580. PubMed ID: 26582748
[TBL] [Abstract][Full Text] [Related]
20. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM
Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
